金权,方臻飞

• 1:中南大学湘雅二医院心血管内科

摘要(Abstract)：

主动脉瓣狭窄会导致不同程度的心脏结构损伤，大量临床研究证实，严重的心脏结构损伤与重度主动脉瓣狭窄患者的不良预后相关。为进一步了解心脏结构损伤与主动脉瓣狭窄的关系，2017年首次提出了基于超声心动图的心脏损伤分期，用以评估心脏结构损伤的程度及其对主动脉瓣狭窄患者预后的影响，随后被诸多研究不断证实与修订。这一分期系统有助于对主动脉瓣狭窄患者进行风险分层，合理选择手术干预时机，优化治疗策略，进而改善主动脉瓣狭窄患者的预后。本文将从病理生理机制、临床应用场景、长期预后预测价值以及未来发展方向进行阐述。

关键词(KeyWords)： 主动脉瓣狭窄;心脏损伤分期;主动脉瓣置换术;预后;研究进展

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 金权,方臻飞

参考文献(References)：

• [1] Durko AP,Osnabrugge RL,Van Mieghem NM,et al. Annual number of candidates for transcatheter aortic valve implantation per country:current estimates and future projections[J]. Eur Heart J,2018,39(28):2635-2642. DOI:10.1093/eurheartj/ehy107.
• [2] Baumgartner H, Falk V, Bax JJ,et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease[J].Eur Heart J,2017,38(36):2739-2791. DOI:10.1093/eurheartj/ehx391.
• [3] Nishimura RA,Otto CM,Bonow RO,et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines[J]. Circulation,2017,135(25):e1159-e1195. DOI:10.1161/CIR.0000000000000503.
• [4] Unger P, Dedobbeleer C, Van Camp G, et al. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement[J]. Heart, 2010, 96(1):9-14. DOI:10.1136/hrt.2009.165548.
• [5] Zilberszac R, Gleiss A, Binder T,et al. Prognostic relevance of mitral and tricuspid regurgitation in patients with severe aortic stenosis[J]. Eur Heart J Cardiovasc Imaging,2018,19(9):985-992. DOI:10.1093/ehjci/jey027.
• [6] Asami M, Stortecky S, Praz F, et al. Prognostic value of right ventricular dysfunction on clinical outcomes after transcatheter aortic valve replacement[J]. JACC Cardiovasc Imaging,2019, 12(4):577-587. DOI:10.1016/j.jcmg.2017.12.015.
• [7] Généreux P, Pibarot P, Redfors B,et al. Staging classifi cation of aortic stenosis based on the extent of cardiac damage[J].Eur Heart J,2017,38(45):3351-3358. DOI:10.1093/eurheartj/ehx381.
• [8] Tan TC, Flynn AW, Chen-Tournoux A,et al. Risk prediction in aortic valve replacement:incremental value of the preoperative echocardiogram[J]. J Am Heart Assoc, 2015,4(10):e002129. DOI:10.1161/JAHA.115.002129.
• [9] Fukui M,Gupta A,Abdelkarim I,et al. Association of structural and functional cardiac changes with transcatheter aortic valve replacement outcomes in patients with aortic stenosis[J]. JAMA Cardiol,2019,4(3):215-222. DOI:10.1001/jamacardio.2018.4830.
• [10] Tastet L, Tribouilloy C, Maréchaux S, et al. Staging cardiac damage in patients with asymptomatic aortic valve stenosis[J].J Am Coll Cardiol,2019,74(4):550-563. DOI:10.1016/j.jacc.2019.04.065.
• [11] Vollema EM, Amanullah MR, Ng ACT,et al. Staging cardiac damage in patients with symptomatic aortic valve stenosis[J].J Am Coll Cardiol,2019,74(4):538-549. DOI:10.1016/j.jacc.2019.05.048.
• [12] Vollema EM, Amanullah MR, Prihadi EA, et al. Incremental value of left ventricular global longitudinal strain in a newly proposed staging classifi cation based on cardiac damage in patients with severe aortic stenosis[J]. Eur Heart J Cardiovasc Imaging,2020, 21(11):1248-1258. DOI:10.1093/ehjci/jeaa220.
• [13] Maeder MT, Weber L, Weilenmann D, et al. Invasive hemodynamic staging classifi cation of cardiac damage in patients with aortic stenosis undergoing valve replacement[J]. Can J Cardiol, 2020, 36(10):1667-1674. DOI:10.1016/j.cjca.2020.02.004.
• [14] Ando T, Ashraf S, Villablanca P, et al. Meta-analysis of ef fectiveness and safety of transcatheter aortic valve implantation versus surgical aortic valve replacement in low-to-intermediate surgical risk cohort[J]. Am J Cardiol,2019,124(4):580-585. DOI:10.1016/j.amjcard.2019.05.017.
• [15] Baron SJ, Wang K, House JA,et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk:results from the PARTNER 2 trial[J]. Circulation, 2019, 139(7):877-888. DOI:10.1161/CIRCULATIONAHA.118.035236.
• [16] Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aorticvalve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med, 2019, 380(18):1706-1715.DOI:10.1056/NEJMoa1816885.
• [17] Mack MJ, Leon MB, Thourani VH,et al. Transcatheter aorticvalve replacement with a balloon-expandable valve in low-risk patients[J]. N Engl J Med,2019,380(18):1695-1705.DOI:10.1056/NEJMoa1814052.
• [18] Gomes WJ, Almeida RMS, Petrucci O,et al. The 2020American College of Cardiology/American Heart Association(ACC/AHA)guideline for the management of patients with valvular heart disease. Should the world jump in?[J].Braz J Cardiovasc Surg, 2021, 36(2):278-288. DOI:10.21470/1678-9741-2021-0953.
• [19] Vahanian A, Beyersdorf F, Praz F,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J].Eur Heart J, 2022, 43(7):561-632. DOI:10.1093/eurheartj/ehab395.
• [20]中国医师协会心血管内科医师分会结构性心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识（2021版）[J].中国介入心脏病学杂志，2022, 30(1):7-16.DOI:10.3969/j.issn.1004-8812.2022.01.002.
• [21]冯晔子，曹丰，李苏雷，等.主动脉瓣重度狭窄患者经导管主动脉瓣置换术的安全性和有效性分析[J].中国介入心脏病学杂志，2022, 30(1):29-32. DOI:10.3969/j.issn.1004-8812.2022.01.005.
• [22] Zhu Q,Yuan Z,Xu Y,et al. Validation of a novel staging classifi cation system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement:a single-center retrospective study[J]. Catheter Cardiovasc Interv,2022,99 Suppl 1:1482-1489. DOI:10.1002/ccd.30147.
• [23] Lancellotti P, Donal E, Magne J,et al. Risk stratifi cation in asymptomatic moderate to severe aortic stenosis:the importance of the valvular, arterial and ventricular interplay[J]. Heart,2010,96(17):1364-1371. DOI:10.1136/hrt.2009.190942.
• [24] Capoulade R, Le Ven F, Clavel MA,et al. Echocardiographic predictors of outcomes in adults with aortic stenosis[J].Heart, 2016, 102(12):934-942. DOI:10.1136/heartjnl-2015-308742.
• [25] Taniguchi T, Morimoto T, Shiomi H,et al. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis[J]. JACC Cardiovasc Interv, 2018, 11(2):145-157. DOI:10.1016/j.jcin.2017.08.036.
• [26] Ito S, Miranda WR, Nkomo VT,et al. Reduced left ventricular ejection fraction in patients with aortic stenosis[J]. J Am Coll Cardiol,2018,71(12):1313-1321. DOI:10.1016/j.jacc.2018.01.045.
• [27] Lancellotti P, Magne J, Dulgheru R,et al. Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics[J]. JAMA Cardiol,2018,3(11):1060-1068. DOI:10.1001/jamacardio.2018.3152.
• [28] Dahl JS, Magne J, Pellikka PA, et al. Assessment of subclinical left ventricular dysfunction in aortic stenosis[J].JACC Cardiovasc Imaging,2019,12(1):163-171. DOI:10.1016/j.jcmg.2018.08.040.
• [29] Magne J, Cosyns B, Popescu BA,et al. Distribution and prognostic signifi cance of left ventricular global longitudinal strain in asymptomatic signifi cant aortic stenosis:an individual participant data Meta-analysis[J]. JACC Cardiovasc Imaging,2019,12(1):84-92. DOI:10.1016/j.jcmg.2018.11.005.
• [30] Généreux P, Pibarot P, Redfors B, et al. Evolution and prognostic impact of cardiac damage after aortic valve replacement[J].J Am Coll Cardiol,2022,80(8):783-800. DOI:10.1016/j.jacc.2022.05.006.
• [31] Falk V, Baumgartner H, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease[J].Eur J Cardiothorac Surg, 2017, 52(4):616-664. DOI:10.1093/ejcts/ezx324.
• [32] Généreux P, Stone GW, O’Gara PT,et al. Natural history,diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis[J]. J Am Coll Cardiol, 2016, 67(19):2263-2288. DOI:10.1016/j.jacc.2016.02.057.
• [33] Kang DH,Park SJ,Lee SA,et al. Early surgery or conservative care for asymptomatic aortic stenosis[J]. N Engl J Med,2020,382(2):111-119. DOI:10.1056/NEJMoa1912846.
• [34] Friedberg MK, Redington AN. Right versus left ventricular failure:differences, similarities, and interactions[J].Circulation, 2014, 129(9):1033-1044. DOI:10.1161/CIRCULATIONAHA.113.001375.
• [35] Mohammed SF,Hussain I,AbouEzzeddine OF,et al. Right ventricular function in heart failure with preserved ejection fraction:a community-based study[J]. Circulation,2014,130(25):2310-2320. DOI:10.1161/CIRCULATIONAHA.113.008461.
• [36] Potus F, Ruffenach G, Dahou A, et al. Downregulation of MicroRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension[J]. Circulation,2 0 1 5, 1 3 2(1 0):9 3 2-9 4 3. D O I:1 0. 1 1 6 1/CIRCULATIONAHA.115.016382.
• [37] Lindman BR, Clavel MA, Mathieu P,et al. Calcific aortic stenosis[J]. Nat Rev Dis Primers, 2016, 2:16006. DOI:10.1038/nrdp.2016.6.
• [38] Busse A, Rajagopal R, Yücel S,et al. Cardiac MRI-Update2020[J]. Radiologe,2020,60(Suppl 1):33-40. DOI:10.1007/s00117-020-00687-1.
• [39] Mayr A, Reiter G, Beitzke D. Cardiac magnetic resonance imaging:trends and developments[J]. Radiologe, 2020,60(12):1142-1152. DOI:10.1007/s00117-020-00766-3.
• [40]石春彦，张宏凯，高一峰，等.二叶式主动脉瓣患者左心室心肌应变参数磁共振定量研究[J].心肺血管病杂志，2022,41(2),179-183. DOI:10.3969/j.issn.1007-5062.2022.02.014